ZimVie Inc
ZimVie Inc operates in the Health Care Equipment & Supplies industry, generating revenue through the sale of dental and medical products.
Business. ZimVie Inc (ZIMV.O) is a health care equipment and supplies company that operates within the medical device industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. ZimVie is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ZimVie Inc (ZIMV.O) is a health care equipment and supplies company that operates within the medical device industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. ZimVie is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.
ZimVie maintains a capital structure characterized by moderate leverage and adequate short-term liquidity. The company holds total assets of $753.7 million against total liabilities of $372.0 million, resulting in total equity of $381.7 million. Long-term debt stands at $220.5 million, yielding a debt-to-equity ratio of 0.58. Liquidity is supported by a current ratio of 1.92, indicating sufficient current assets to cover current liabilities. However, the company reports negative net cash, as cash and equivalents of $75.0 million are insufficient to offset total debt obligations. Operating cash flow is positive at $14.2 million, but free cash flow is negative at -$6.2 million due to capital expenditures of $6.7 million.
Profitability metrics indicate operational challenges in the latest period. The company reported revenue of $449.7 million and gross profit of $287.4 million, implying a gross margin of approximately 63.9%. Despite healthy gross margins, operating income is negative at -$20.7 million, leading to a net loss of -$25.8 million. Return on equity is -5.1%, and return on assets is -2.6%, reflecting the inability to generate positive returns on invested capital during this period. These figures suggest that operating expenses and interest costs are currently exceeding operating income.
Segment and geographic data are not provided in the available input, preventing a detailed analysis of revenue concentration or regional exposure. The company’s business activity is broadly defined within the Health Care Equipment & Supplies sector, but specific product mix or customer concentration risks cannot be quantified from the current dataset.
Growth trajectory analysis is limited by the absence of historical period data in the input. Without multi-year revenue or net income trends, it is not possible to assess the direction or velocity of revenue growth or profitability improvement. The single-period snapshot shows a revenue base of $449.7 million, but year-over-year changes are not disclosed.
Risk assessment highlights medium liquidity risk and low dilution risk. A key flag notes that net cash is negative after subtracting total debt, which may constrain financial flexibility. The company has 28.2 million basic shares outstanding, with no difference between basic and diluted shares, suggesting minimal immediate dilution from options or convertible securities. The low dilution risk rating supports the stability of the current share count.
Recent observations include an actual EPS of $0.62 and actual revenue of $449.7 million, which may reflect a prior period or adjusted figure given the current net loss. ESG metrics show a total score of 29.29 with a grade of C-, driven by a low environment pillar score of 13.13 and a governance score of 24.38, though the social pillar is higher at 38.73. The ESG controversies score is 100, indicating no significant controversies.
- ZimVie reports a net loss of $25.8 million on revenue of $449.7 million, with negative operating income of $20.7 million.
- The company has a debt-to-equity ratio of 0.58 and a current ratio of 1.92, indicating moderate leverage and adequate short-term liquidity.
- Free cash flow is negative at -$6.2 million, despite positive operating cash flow of $14.2 million, due to capital expenditures.
- Net cash is negative, as cash and equivalents of $75.0 million do not cover long-term debt of $220.5 million.
- Dilution risk is assessed as low, with no difference between basic and diluted shares outstanding.
- ESG performance is rated C- with a total score of 29.29, highlighting weaknesses in environmental and governance pillars.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue $116.7M, −0,1% YoY; Operating income +119,3% YoY.
- ▍Revenue $116.7M, −0,1% YoY
- ▍Operating income +119,3% YoY
- ▍Net income +1,7% YoY
- ▍Free cash flow +237,8% YoY
- ▍Net margin -3.4%
Revenue $112.0M, −5,2% YoY; Operating income +127,8% YoY.
- ▍Revenue $112.0M, −5,2% YoY
- ▍Operating income +127,8% YoY
- ▍Net income +81,0% YoY
- ▍Free cash flow +185,7% YoY
- ▍Net margin -1.3%
Revenue $111.5M; Operating income -$6.3M.
- ▍Revenue $111.5M
- ▍Operating income -$6.3M
- ▍Free cash flow +95,7% YoY
- ▍Net margin -10.6%
Revenue $103.2M, −2,0% YoY; Operating income −24,6% YoY.
- ▍Revenue $103.2M, −2,0% YoY
- ▍Operating income −24,6% YoY
- ▍Net income +55,1% YoY
- ▍Free cash flow −67,3% YoY
- ▍Net margin -2.2%
Revenue $116.8M; Operating income -$6.7M.
- ▍Revenue $116.8M
- ▍Operating income -$6.7M
- ▍Net margin -3.4%
Revenue $118.2M; Operating income -$2.8M.
- ▍Revenue $118.2M
- ▍Operating income -$2.8M
- ▍Net margin -6.6%
Revenue $105.3M; Operating income -$3.9M.
- ▍Revenue $105.3M
- ▍Operating income -$3.9M
- ▍Net margin -4.8%
Revenue $449.7M, −1,7% YoY; Operating income +33,2% YoY.
- ▍Revenue $449.7M, −1,7% YoY
- ▍Operating income +33,2% YoY
- ▍Net income +93,4% YoY
- ▍Free cash flow +81,7% YoY
- ▍Net margin -5.7%
Revenue $457.4M, −1,3% YoY; Operating income +33,5% YoY.
- ▍Revenue $457.4M, −1,3% YoY
- ▍Operating income +33,5% YoY
- ▍Net income −515,6% YoY
- ▍Free cash flow +94,1% YoY
- ▍Net margin -86.0%
Revenue $463.3M, −1,9% YoY; Operating income −313,1% YoY.
- ▍Revenue $463.3M, −1,9% YoY
- ▍Operating income −313,1% YoY
- ▍Net income +32,9% YoY
- ▍Free cash flow −53 607,5% YoY
- ▍Net margin -13.8%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Return On Equitynet_income / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Return On Assetsnet_income / total_assets
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- ZimVie Inc Market data — financials · 2026-07-26
- ZimVie Inc Market data — analyst estimates · 2026-07-26
- ZimVie Inc Market data — ESG · 2026-07-26
Ownership & reference
Top holders
- Investment Managers · as of 2024-06-300,00 %$33M
- Investment Managers · as of 2024-12-310,00 %$1M
- Institutional Investor · as of 2022-09-300,00 %$0M